Dr. Jeffrey Gelblum, MD, FAAN, Senior Neurology Attending & Partner, First Choice Neurology

First Choice Neurology: Pioneering Partner in the World’s Largest Neurology Data Platform

Dr. Jeffrey Gelblum shares how First Choice Neurology's active participation in the NeuroDiscovery AI platform is revolutionizing neurological research and clinical trial efficiency. As a founding partner in the world's largest repository of neurology clinical data, First Choice Neurology is helping accelerate research timelines from years to months through unprecedented data accessibility and real-world outcomes analysis.

Dr. Jeffrey Gelblum, MD, FAAN

Senior Neurology Attending & Partner, First Choice Neurology

Platform Impact on Research Efficiency:

Traditional clinical trial cohort assembly for specialized patient populations (e.g., females aged 30-50 with specific MS lesion patterns and cognitive deficiency) could take 2-3 years. With NDAI's aggregated EMR data from hundreds of neurologists nationwide, the same cohort can be identified and assembled in minutes, reducing study timelines by up to 80%.

Data Security & Compliance:

All patient data fully sanitized and de-identified
U.S.-based software development and management
Robust security protocols preventing data breaches
Complete HIPAA compliance with anonymous clinical data sharing

Practice Focus:

Comprehensive neurology care with active clinical research participation across multiple neurological conditions, particularly multiple sclerosis.

First Choice Neurology's participation enables pharmaceutical companies and clinical researchers to access comprehensive real-world data for treatment evaluation, biomarker studies, and outcomes research across the full spectrum of neurological care.

Quote Highlight

“NDAI can generate that cohort in literally minutes. So a study that could have taken previously three years maybe takes only six months.”

Key Platform Benefits Discussed:

Accelerated Clinical Research: Patient cohort identification that traditionally took months or years now completed in minutes
Massive Data Repository: Access to over 5 million neurology patient lives with comprehensive clinical data
Real-World Outcomes Analysis: Immediate access to treatment responses, biomarker confirmations, and patient outcomes across multiple neurological conditions
Enhanced Trial Recruitment: Rapid identification of specific patient cohorts for Phase III FDA trials and clinical studies
U.S.-Based Security: HIPAA-compliant, onshore data management with robust patient privacy protections

Client Success Stories

Dr. Martin Belkin, Medical Director, MIND MS Center

Michigan Institute for Neurological Disorders: Founding Partner in National Neurology Alliance

Michigan Institute for Neurological Disorders (MIND)

Learn more

Raleigh Neurology Associates Partners with NeuroDiscovery AI to Transform Patient Care

Dr. John Scagnelli, Raleigh Neurology Associates, Raleigh, North Carolina

Learn more

Dr. Laszlo Mechtler — Dent Neurologic Institute interview with NeuroDiscovery AI

Dent Neurologic Institute Partners with NeuroDiscovery AI to Advance Data-Driven Neurology Care

Dr. Laszlo Mechtler, Professor of Neurology and Oncology, Dent Neurologic Institute, Buffalo, New York

Learn more

Stay Informed

Subscribe to our research newsletter for updates on new datasets, research findings, and collaboration opportunities